🇪🇺 Alhemo in European Union

Alhemo (CONCIZUMAB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/005938
  • Local brand name: Alhemo
  • Status: approved

Alhemo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in European Union

Frequently asked questions

Is Alhemo approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Alhemo in European Union?

Novo Nordisk Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.